Poly(ADP-ribose) in the skin and in melanomas.
暂无分享,去创建一个
G. Emri | É. Szabó | L. Virág | J. Németh | P. Bai | É. Remenyik | E. Bodnár | P. Gergely | Z. Géhl
[1] A. Ashworth,et al. Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. , 2009, The New England journal of medicine.
[2] É. Szabó,et al. Dual role of poly(ADP‐ribose) glycohydrolase in the regulation of cell death in oxidatively stressed A549 cells , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[3] A. Harris,et al. Phase I Study of the Poly(adp-ribose) Polymerase Inhibitor, Ag014699, in Combination Withtemozolomide in Patients with Advanced Solid Tumors Cancer Therapy: Clinical , 2022 .
[4] A. Chalmers. The potential role and application of PARP inhibitors in cancer treatment. , 2008, British medical bulletin.
[5] Takami Sato,et al. The biology and management of uveal melanoma , 2008, Current oncology reports.
[6] A. Scriven,et al. Sun safety: what are the health messages? , 2008, The journal of the Royal Society for the Promotion of Health.
[7] H. Dao,et al. Gender differences in skin: a review of the literature. , 2007, Gender medicine.
[8] V. D’Hondt,et al. Novel treatment strategies for malignant melanoma: a new beginning? , 2007, Critical reviews in oncology/hematology.
[9] R. Swanson,et al. Novel modulators of poly(ADP-ribose) polymerase. , 2006, Trends in pharmacological sciences.
[10] Chin-Lin Hsu,et al. Induction of cell apoptosis in 3T3-L1 pre-adipocytes by flavonoids is associated with their antioxidant activity. , 2006, Molecular nutrition & food research.
[11] V. Schreiber,et al. Poly(ADP-ribose): novel functions for an old molecule , 2006, Nature Reviews Molecular Cell Biology.
[12] C. Glass,et al. A Topoisomerase IIß-Mediated dsDNA Break Required for Regulated Transcription , 2006, Science.
[13] M. Piris,et al. Inhibition of poly(ADP-ribose) polymerase modulates tumor-related gene expression, including hypoxia-inducible factor-1 activation, during skin carcinogenesis. , 2006, Cancer research.
[14] C. Leonetti,et al. Poly(ADP-ribose) glycohydrolase inhibitor as chemosensitiser of malignant melanoma for temozolomide. , 2005, European journal of cancer.
[15] K. Murthy,et al. Gender Differences in the Endotoxin-Induced Inflammatory and Vascular Responses: Potential Role of Poly(ADP-ribose) Polymerase Activation , 2005, Journal of Pharmacology and Experimental Therapeutics.
[16] G. Argenziano,et al. Poly(adenosine diphosphate-ribose) polymerase 1 expression in malignant melanomas from photoexposed areas of the head and neck region. , 2005, Human pathology.
[17] L. McCullough,et al. Ischemic Nitric Oxide and Poly (ADP-Ribose) Polymerase-1 in Cerebral Ischemia: Male Toxicity, Female Protection , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[18] C. Szabó,et al. Pathophysiologic role of oxidative stress-induced poly(ADP-ribose) polymerase-1 activation: focus on cell death and transcriptional regulation. , 2005, Cellular and molecular life sciences : CMLS.
[19] G. Seigel,et al. Poly(ADP-ribose) polymerase inhibitors counteract diabetes- and hypoxia-induced retinal vascular endothelial growth factor overexpression. , 2004, International journal of molecular medicine.
[20] Changlian Zhu,et al. PARP‐1 gene disruption in mice preferentially protects males from perinatal brain injury , 2004, Journal of neurochemistry.
[21] G. de Murcia,et al. The PARP superfamily , 2004, BioEssays : news and reviews in molecular, cellular and developmental biology.
[22] Arun D. Singh,et al. Sunlight exposure and pathogenesis of uveal melanoma. , 2004, Survey of ophthalmology.
[23] A. Ormerod,et al. Nitric oxide function in the skin. , 2004, Nitric oxide : biology and chemistry.
[24] C. Szabó,et al. Cytoprotective effect of gallotannin in oxidatively stressed HaCaT keratinocytes: the role of poly(ADP‐ribose) metabolism , 2004, Experimental dermatology.
[25] C. Leonetti,et al. Systemic administration of GPI 15427, a novel poly(ADP-ribose) polymerase-1 inhibitor, increases the antitumor activity of temozolomide against intracranial melanoma, glioma, lymphoma. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[26] L. Csernoch,et al. Role of intracellular calcium mobilization and cell-density-dependent signaling in oxidative-stress-induced cytotoxicity in HaCaT keratinocytes. , 2003, The Journal of investigative dermatology.
[27] P. Elsner,et al. Oxidative stress in malignant melanoma and non‐melanoma skin cancer , 2003, The British journal of dermatology.
[28] R. Bakos,et al. Sunburn, sunscreens, and phenotypes: some risk factors for cutaneous melanoma in southern Brazil , 2002, International journal of dermatology.
[29] C. Szabó,et al. The Therapeutic Potential of Poly(ADP-Ribose) Polymerase Inhibitors , 2002, Pharmacological Reviews.
[30] B. Sümegi,et al. Reduction of acute photodamage in skin by topical application of a novel PARP inhibitor. , 2002, Biochemical pharmacology.
[31] D. Schadendorf. Is There a Standard for the Palliative Treatment of Melanoma? , 2002, Oncology Research and Treatment.
[32] A. Kozubík,et al. Multiple biological effects of inhibitors of arachidonic acid metabolism on human keratinocytes , 2002, Archives of Dermatological Research.
[33] É. Szabó,et al. Detection of Poly(ADP-ribose) Polymerase Activation in Oxidatively Stressed Cells and Tissues Using Biotinylated NAD Substrate , 2002, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[34] U. Reichert,et al. Limited cooperation between peroxisome proliferator-activated receptors and retinoid X receptor agonists in sebocyte growth and development. , 2001, Molecular genetics and metabolism.
[35] É. Szabó,et al. Peroxynitrite production, DNA breakage, and poly(ADP-ribose) polymerase activation in a mouse model of oxazolone-induced contact hypersensitivity. , 2001, The Journal of investigative dermatology.
[36] K. Hood,et al. Does Experience Predict Knowledge and Behavior With Respect to Cutaneous Melanoma, Moles, and Sun Exposure? Possible Outcome Measures , 2000, Behavioral medicine.
[37] M. Picardo,et al. Antioxidant pattern in uveal melanocytes and melanoma cell cultures. , 1999, Investigative ophthalmology & visual science.
[38] T. Kakizawa,et al. Inhibition of Nuclear Receptor Signalling by Poly(ADP-Ribose) Polymerase , 1999, Molecular and Cellular Biology.
[39] A. Kentsis,et al. Rat preputial sebocyte differentiation involves peroxisome proliferator-activated receptors. , 1999, The Journal of investigative dermatology.
[40] I. Ahmed. Malignant melanoma: prognostic indicators. , 1997, Mayo Clinic proceedings.
[41] A. Kopf,et al. Risk of developing multiple primary cutaneous melanomas in patients with the classic atypical‐mole syndrome: a case‐control study , 1996, The British journal of dermatology.
[42] Gernot Rassner,et al. Primary cutaneous melanoma. Identification of prognostic groups and estimation of individual prognosis for 5093 patients , 1995, Cancer.
[43] D. Moore,et al. Nevus counting as a risk factor for melanoma: comparison of self-count with count by physician. , 1994, Journal of the American Academy of Dermatology.
[44] M. Malanga,et al. Poly(ADP-ribose) molecules formed during DNA repair in vivo. , 1994, The Journal of biological chemistry.
[45] J. M. Murcia,et al. Poly(ADP-ribose) polymerase: a molecular nick-sensor. , 1994, Trends in biochemical sciences.
[46] D. Guerry,et al. Disseminated melanoma--is there a new standard therapy? , 1992, The New England journal of medicine.
[47] O. Janssen,et al. Differentiation of 3T3-L1 pre-adipocytes induced by inhibitors of poly(ADP-ribose) polymerase and by related noninhibitory acids. , 1989, European journal of biochemistry.
[48] É. Szabó,et al. Poly(ADP-ribose) polymerase mediates inflammation in a mouse model of contact hypersensitivity. , 2009, The Journal of investigative dermatology.
[49] M. Hottiger,et al. The diverse biological roles of mammalian PARPS, a small but powerful family of poly-ADP-ribose polymerases. , 2008, Frontiers in bioscience : a journal and virtual library.
[50] U. Förstermann,et al. Involvement of NO in contact hypersensitivity. , 1998, International immunology.